Tissue microenvironment and paracrine signaling pathways (TME)

The tissue microenvironment (TME) and paracrine signaling pathways represent the complex ecosystem surrounding cells, comprising the extracellular matrix (ECM), blood vessels, immune cells, fibroblasts, and signaling molecules [NCI, 2024]. Paracrine signaling is a form of cell-to-cell communication where a cell produces a signal to induce changes in nearby cells, which is essential for maintaining tissue homeostasis and coordinating local physiological responses [Nature Education, 2014]. In pathological conditions such as cancer, the TME is often "reprogrammed" by the tumor to support growth, facilitate immune evasion, and promote metastasis through aberrant paracrine loops involving cytokines, chemokines, and growth factors [Hanahan & Weinberg, 2011]. While not a single molecular target, the TME is a major focus of therapeutic intervention, with drugs designed to disrupt these local interactions or normalize the niche [Anderson & Simon, 2020]. For instance, anti-angiogenic agents like Bevacizumab target vascular growth factors, while immune checkpoint inhibitors like Pembrolizumab reactivate exhausted T-cells within the TME [FDA]. Understanding the spatial and temporal dynamics of these pathways is critical for developing effective combination therapies and overcoming drug resistance in various diseases, including fibrosis and chronic inflammation.

Other names

Tumor microenvironmentStromaCellular nicheLocal signaling environment

Modulation of the local cellular and biochemical environment through the inhibition of specific paracrine factors, immune checkpoints, or extracellular matrix components to restore homeostasis or enhance therapeutic efficacy.